Which exoskeleton suits home rehab? We compare EksoNR, HAL, Atalante X, Indego and ExoMotus M4 on weight, battery, certifications and deployment constraints.
ExoSelect researchContinue reading
Editorial QA
Checked for sourced parameters, internal links and prohibited claims.
| System | Maker | Weight | User weight | Battery life | Certifications | Price |
|---|---|---|---|---|---|---|
| EksoNR | Ekso Bionics | 23.6 kg | 100 kg | 4 h | FDA, CE | Undisclosed |
| HAL Lower Limb | Cyberdyne | 17 kg | 100 kg | 3 h | CE medical, ISO 13485 | Undisclosed (lease/programme) |
| Atalante X | Wandercraft | 65 kg | 100 kg | 4 h | CE medical | Undisclosed |
| Indego | Parker Hannifin | 12.3 kg | 113 kg | 4 h | FDA, CE | Undisclosed |
| ExoMotus M4 | Fourier Intelligence | 23.5 kg | 100 kg | 3 h | NMPA, CE | Undisclosed |
All prices are undisclosed in the database; buyers must request quotes. For a deeper comparison, see our comparison tool or browse the medical exoskeleton category.
Several critical parameters for home rehabilitation are missing from the supplied data. These gaps matter because home use demands different safety and usability thresholds than clinical settings.
These unknowns mean buyers must request documented values from manufacturers and verify home-use suitability with local regulators.
If you are a patient or family member seeking an exoskeleton for independent home use without clinical oversight, none of these systems are appropriate. All are designed for therapist-supervised rehabilitation; using them unsupervised could be unsafe. Similarly, buyers with a tight budget should not proceed without confirmed pricing and reimbursement pathways—all prices are undisclosed, and HAL is often leased rather than sold. Finally, if your home has limited space or stairs, avoid the Atalante X (65 kg, not for stairs) and consider lighter options like Indego, but only after a clinical assessment.
Home use introduces constraints not present in clinics. Weight and portability: Indego (12.3 kg) is the lightest, while Atalante X (65 kg) is impractical for home transport. Battery life: 3–4 hours may suffice for daily sessions, but charge times (2–3 hours) and swappable batteries help. Space: Atalante X's self-balancing mode requires clearance; others need therapist space. Regulatory: FDA clearance for EksoNR and Indego is for clinical use; home use may require additional approvals. Training: all systems require therapist supervision, so home use necessitates caregiver training, which is not quantified in the data.
No prices are disclosed, but home rehabilitation adds costs: training for caregivers, maintenance (warranty is 12 months for all), battery replacement, and potential home modifications. HAL's lease model may reduce upfront cost but adds recurring fees. Buyers should request total cost of ownership from makers, including service contracts and spare parts.
Certifications vary by region: EksoNR and Indego have FDA (US) and CE (Europe); HAL has CE medical and ISO 13485; ExoMotus M4 has NMPA (China) and CE; Atalante X has CE medical only. For home use, check if the certification covers home healthcare (e.g., IEC 60601-1-11). None list this, so buyers must confirm with manufacturers. Also, availability regions differ: EksoNR covers North America, Europe, Asia-Pacific; HAL covers Japan, Europe, Asia-Pacific; Atalante X covers Europe, North America; Indego covers North America, Europe; ExoMotus M4 covers Asia-Pacific, Europe, Middle East.
No. All systems in this dataset are intended for therapist-supervised rehabilitation. Home use without supervision is not supported by the supplied data and may be unsafe.
Indego is the most home-friendly due to its lower weight (12.3 kg) and higher user weight capacity (113 kg), but it still requires clinical oversight. Buyers must verify home-use clearance.
No. All prices are undisclosed. HAL is often offered as a lease or treatment programme. Contact manufacturers for quotes.
Request a documented home-use certification and peak assist force value from Parker Hannifin for the Indego, or contact our selection desk for a tailored comparison based on your clinical and home environment requirements.
Editorial note
This analysis is based on published specifications and named sources. No first-party physical evaluation was performed.
Reviewed by the ExoSelect editorial desk
